| Companies sponsors |
Astellas (enfortumab vedotin) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Action Bladder Cancer UK |
| |
Fight Bladder Cancer |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Comparator companies |
Merck Sharp and Dohme (pembrolizumab) (confidentiality agreement signed, participating) |
| |
Roche (atezolizumab) (confidentiality agreement signed, participating) |
| |
Advanz Pharma (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Amgen (filgrastim, pegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Baxter (doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Chugai Pharma (lenograstim) (confidentiality agreement not signed, not participating) |
| |
Cipla (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (carboplatin, cisplatin, gemcitabine, methotrexate, vinblastine) (confidentiality agreement not signed, not participating) |
| |
Medac GmbH (doxorubicin, methotrexate) (confidentiality agreement not signed, not participating) |
| |
Morningside Healthcare (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Napp Pharmaceuticals (pegfilgrastim) (confidentiality agreement not signed, not participating) |
| |
Pfizer (methotrexate, doxorubicin, filgrastim) (confidentiality agreement not signed, not participating) |
| |
Rosemont Pharmaceuticals (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Sandoz (cisplatin, pegfilgrastim, filgrastim) (confidentiality agreement not signed, not participating) |
| |
Seacross Pharmaceuticals (doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Sun Pharmaceutical (gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Synchrony Pharma (gemcitabine) (confidentiality agreement not signed, not participating) |
| |
Therakind (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Teva Pharma (lipegfilgrastim) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |